Also, don’t miss Celebrate Autumn, Cherish Memories, Fight Alzheimer’s — Online Rally Nov. 6! on the Redmond Patch calendar ...

Edesa Biotech has announced its participation in upcoming conferences, including BIO-Europe in Vienna and the LSX Investival Showcase in London. This participation highlights Edesa’s ongoing efforts ...

Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management ...

The post Day 4 Of AFROTECH™ Conference 2025 Delivered Insights On Design, Wealth Building, And Human Connection In The Age Of AI appeared first on AfroTech. The post Day 4 Of AFROTECH™ Conference 2025 ...

The Artiva management team will also be available to participate in investor meetings with investors who are registered to attend the conferences.

Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...

MENLO PARK, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for ...

Importantly, BGE-102 is an oral candidate. The current leaders in the anti-obesity market are administered via subcutaneous ...